# Sagimet Biosciences Inc. (SGMT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SGMT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -10.65M | $ -8.61M | $ 39.0K | $ 102.46M |
| 2025 | $ 0 | $ -52.26M | $ -46.74M | $ 78.0K | $ 111.38M |
| 2024 | $ 0 | $ -47.89M | $ -44.60M | $ 78.0K | $ 155.81M |
| 2023 | $ 2.16M | $ -30.14M | $ -25.70M | $ 65.0K | $ 91.07M |
| 2022 | $ 0 | $ -34.07M | $ -27.36M | $ 211.0K | $ -186.95M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.05 |
| Current Ratio | 20.34 |

## Other views

- [Metrics](https://sponda.capital/en/SGMT.md)
- [Charts](https://sponda.capital/en/SGMT/charts.md)
- [Compare](https://sponda.capital/en/SGMT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.